MTOR and colorectal carcinoma: To date, the interplay of Wnt/β-catenin signaling with several pathways implicated in CRC carcinogenesis is well-known, including the phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR) [7].